These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2982958)

  • 1. Newer directions in vaccine development and utilization.
    Hilleman MR
    J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis virus vaccines: present status.
    Krugman S
    Yale J Biol Med; 1982; 55(3-4):375-81. PubMed ID: 6295013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The future of viral hepatitis vaccines].
    Shdanov VM
    Z Gesamte Hyg; 1985 Mar; 31(3):134-7. PubMed ID: 2990115
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines against hepatitis A and B.
    Zuckerman AJ
    Baillieres Clin Gastroenterol; 1990 Sep; 4(3):775-88. PubMed ID: 1962731
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral Hepatitis: a review.
    Neimark S; Rogers AI
    Am J Gastroenterol; 1982 Jun; 77(6):431-5. PubMed ID: 6283881
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines to prevent hepatitis B and hepatitis A virus infections.
    Hadler SC
    Infect Dis Clin North Am; 1990 Mar; 4(1):29-46. PubMed ID: 2155262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B and primary liver cancer.
    Harrison TJ; Chen JY; Zuckerman AJ
    Cancer Treat Rev; 1986 Mar; 13(1):1-16. PubMed ID: 3013403
    [No Abstract]   [Full Text] [Related]  

  • 8. The agents of human viral hepatitis, and control of the disease.
    Deinhardt F
    Prog Med Virol; 1984; 30():14-28. PubMed ID: 6087411
    [No Abstract]   [Full Text] [Related]  

  • 9. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
    Smith GL; Mackett M; Moss B
    Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of the problem of viral hepatitis B prophylaxis].
    Golosova TV; Vlasikhina EM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
    [No Abstract]   [Full Text] [Related]  

  • 15. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines released.
    Am J Infect Control; 1995 Jun; 23(3):213. PubMed ID: 7677269
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of antibody formation to the vaccinia virus in human subjects and rabbits in response to the administration of a recombinant vaccinia-hepatitis B vaccine].
    Cheliapov NV; Chernos VI; Andzhaparidze OG
    Vopr Virusol; 1988; 33(2):175-9. PubMed ID: 2842961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of genetic technics for the diagnosis and prevention of hepatitis B virus infections].
    Gerlich WH
    Internist (Berl); 1985 Feb; 26(2):63-7. PubMed ID: 2984133
    [No Abstract]   [Full Text] [Related]  

  • 19. Live recombinant vaccines using genetically engineered vaccinia virus.
    Paoletti E; Perkus ME; Piccini A
    Antiviral Res; 1985; Suppl 1():301-7. PubMed ID: 3866514
    [No Abstract]   [Full Text] [Related]  

  • 20. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.